Florida biotech firm aimed at cancer sells for $70 million

Posted by on Jun 10, 2019

ORLANDO, FL. –  Florida company CytoSen, which developed a new biotech approach to cancer therapies, has sold for about $70 million to Netherlands-based Kiadis Pharma.

CytoSen was spun out of the University of Central Florida in 2014 and grew over the past few years in UCF’s incubator location in Winter Springs. The university is calling it the largest biotech purchase in central Florida history.

Leave a Reply